Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (Q34601527)
scientific article published on 9 December 2008
Language:
(P31) (Q13442814)
(P50) (Q5912759)
(P304) 789-796
(P407) (Q1860)
(P433) 6
(P478) 68
(P577) Tuesday, December 9, 2008
(P921) (Q18032037)
(Q79460)
(Q187255)
(Q422232)
(P1433) (Q4767876)
(P1476) "Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study" (language: en)
(P2093) E C Keystone
M C Genovese
E C Hsia
S T Hall
P C Miranda
J Pazdur
S-C Bae
W Palmer
J Zrubek
M Wiekowski
S Visvanathan
Z Wu
M U Rahman
GO-FORWARD Study
(P2860) (Q36204163)
(Q35954497)
(Q34552451)
(Q34547981)
(Q35554130)
(Q33976382)
(Q34544500)
(Q34530459)
(Q29616063)
(Q33885648)
(Q52221782)
(Q34315745)
(Q27860872)
(Q50546839)
(Q53239672)
(Q47784405)
(Q47643186)
(Q57752112)
(Q70672405)
(Q73235899)
(Q56879288)
(Q77341367)
(Q81811353)
(Q82132610)
(Q79318146)
other details
description scientific article published on 9 December 2008

External Links